Serum luteinizing hormone levels are markedly increased and significantly correlated with Delta 4-androstenedione levels in lean women with polycystic ovary syndrome

Dimitrios Panidis; Dimitrios Farmakiotis; David Rousso; Ilias Katsikis; Anargyros Kourtis; Evanthia Diamanti-Kandarakis

doi:10.1016/j.fertnstert.2005.02.017

Serum luteinizing hormone levels are markedly increased and significantly correlated with Delta 4-androstenedione levels in lean women with polycystic ovary syndrome

Fertil Steril. 2005 Aug;84(2):538-40. doi: 10.1016/j.fertnstert.2005.02.017.

Authors

Dimitrios Panidis¹, Dimitrios Farmakiotis, David Rousso, Ilias Katsikis, Anargyros Kourtis, Evanthia Diamanti-Kandarakis

Affiliation

¹ Division of Endocrinology and Human Reproduction, Second Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Thessaloniki, Greece.

PMID: 16084906
DOI: 10.1016/j.fertnstert.2005.02.017

Abstract

Lean women with polycystic ovary syndrome have markedly increased serum luteinizing hormone levels, which are significantly correlated with Delta(4)-androstenedione levels but not directly linked to insulin resistance.

Publication types

Comparative Study

MeSH terms

Androstenedione / blood*
Female
Humans
Luteinizing Hormone / blood*
Polycystic Ovary Syndrome / blood*
Thinness / blood*

Substances

Androstenedione
Luteinizing Hormone